Medtronic plc completed the acquisition of Israel-based Mazor Robotics Dec. 19.
Under the terms of the acquisition agreement, Mazor shareholders will receive $58.50 per ADS, or $29.25 per ordinary share, in cash. The total value of the transaction is reported at $1.7B, or $1.3B net of Medtronic’s existing stake in Mazor and cash acquired.
Mazor Robotics joins Medtronic’s Neurosurgery business, which is part of the Restorative Therapies Group’s Brain Therapies division. VTN
